This cluster groups 2 independently calculated changes: Cash & equivalents decreased 74.4%; Operating cash flow decreased 40.1%.
2 evidence-backed components· Pharmaceutical Preparations
RESEARCH SNAPSHOTImmuneering Corp's latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents decreased 74.4%; Operating cash flow decreased 40.1%.
2 evidence-backed componentsCash & equivalents changed -74.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
IMRX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001790340-26-000097SEC ↗8-KOct 29, 2026Period Oct 29, 20260001790340-26-000095SEC ↗10-QAug 5, 2026Period Jun 30, 20260001790340-26-000091SEC ↗8-KAug 5, 2026Period Aug 5, 20260001790340-26-000088SEC ↗4Jul 17, 2026Period Jul 16, 20260001790340-26-000082SEC ↗4Jun 24, 2026Period Jun 23, 20260001790340-26-000078SEC ↗4Jun 16, 2026Period Jun 15, 20260001790340-26-000076SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 16, 2026Filed Jul 17, 2026 | Gengos AndrewChief Financial Officer | Grant Or AwardDirect | 650,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Free-cash-flow proxy changed -40.2% from the comparable as-filed period.
Operating income changed -67.7% from the comparable as-filed period.
Operating cash flow changed -40.1% from the comparable as-filed period.
Current assets changed -34.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -41.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -1444 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001790340-26-000074